Abstract:Background: Plasma cell-free DNA Next-Generation Sequencing has been used as a non-invasive and com-prehensive method for the etiological diagnosis of infectious diseases. However, only a handful of studies have described the real-world utility of this technique in patients with hematological disorders, a cohort of patients that are distinctive due to neutropenia and weakened immune functions. Methods: We retrospectively analyzed the results of plasma cell-free DNA sequencing performed on 184 and 163 specimens collected from hematological patients suspected of infections with (Group I) or with-out (Group II) neutropenia, respectively. The diagnostic performance and the clinical impact of plasma sequencing were comparatively evaluated to conventional microbiological tests and a composite refer-ence standard (conventional tests combined with the clinical assessment). Results: The overall positive detection rate of plasma cell-free DNA sequencing was significantly higher than that of conventional microbiological tests (72.6% vs.31.4%, P < 0.001). The positive rate of conven-tional microbiological tests in Group I was lower than that in Group II (25.5% vs. 38.0%, P = 0.012). Com-bining plasma sequencing with conventional tests yielded a positive detection rate of 75.0% and 74.8% for these two groups, respectively. Using the composite reference standard, the sensitivity and specificity of plasma sequencing were 89.1% and 65.1%, respectively. The proportions of the positive impact of cell-free DNA sequencing results in the Group I were higher than in the Group II in terms of both diagnosis and treatment (diagnosis: 54.3% vs. 40.5%, P = 0.013; treatment: 45.7% vs.30.7%, P = 0.004). A total of 73 patients (21.0%) benefited from plasma sequencing through adjustment of the antibiotic regimen. Conclusions: The diagnostic yield of conventional microbiological tests was low in patients with neu-tropenia. Combining conventional tests with plasma cell-free DNA sequencing significantly improved the detection rate for pathogens and optimized antibiotic treatment. Our findings on the clinical im-pact warrant confirmation through larger, multicenter, randomized controlled trials. Moreover, the cost-effectiveness of this testing strategy remains unknown and requires further exploration. (c) 2022 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )

The plasma viral communities associate with clinical profiles in a large-scale haematological patients cohort

Plasma Virome Reveals Blooms and Transmission of Anellovirus in Intravenous Drug Users with HIV-1, HCV, and/or HBV Infections

Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses

Plasma metagenomics reveals regional variations of emerging and re-emerging pathogens in Chinese blood donors with an emphasis on human parvovirus B19

Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19

Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients Plasma

Serial High-Resolution Analysis of Blood Virome and Host Cytokines Expression Profile of a Patient with Fatal H7N9 Infection by Massively Parallel RNA Sequencing.

Plasma Virome of HIV-infected Subjects on Suppressive Antiretroviral Therapy Reveals Association of Differentially Abundant Viruses with Distinct T-cell Phenotypes and Inflammation

3213 – DISSECTING THE BLOOD ECOSYSTEM IN SARS-COV-2 OMICRON PATIENTS

Cataloguing and profiling of the gut virome in Chinese populations uncover extensive viral signatures across common diseases

Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery in Clinic

Utility of Plasma Cell-Free DNA Next-Generation Sequencing for Diagnosis of Infectious Diseases in Patients with Hematological Disorders.

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

Clinical characteristics of hematological patients concomitant with COVID‐19

The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy

Molecular characterization of plasma virome of hepatocellular carcinoma (HCC) patients

The relationships among host transcriptional responses reveal distinct signatures underlying viral infection-disease associations

Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients

Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection

Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis

Plasma Proteomics Unveil Novel Immune Signatures and Biomarkers upon SARS-CoV-2 Infection